Shire Sues Sandoz Over Planned Generic Intuniv

Law360, New York (April 29, 2011, 12:26 PM EDT) -- Shire LLC filed a patent infringement suit against Sandoz Inc. on Wednesday in Colorado over the generics maker’s bid to produce a version of attention deficit hyperactivity disorder drug Intuniv.

The suit is the latest in a string Shire has launched against generics companies over the drug, following one against Mylan Pharmaceuticals Inc. on April 20 and several others last year.

According to the latest suit, Sandoz notified Shire of its abbreviated new drug application for generic Intuniv on March 14. Shire claims that the application...
To view the full article, register now.